2023
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP) (Journal article)
Starkey, T., Ionescu, M., Tilby, M., Little, M. W., Burke, E., Fittall, M., . . . NCRI, C. F. (2023). A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP). SCIENTIFIC REPORTS, 13(1). doi:10.1038/s41598-023-36990-9DOI: 10.1038/s41598-023-36990-9
P-34 The changing risk of hospitalisation, intensive care admission and death due to COVID-19 in patients with gastrointestinal cancer in the UK (Journal article)
Tilby, M., Starkey, T., Ionescu, M., & Lee, L. (2023). P-34 The changing risk of hospitalisation, intensive care admission and death due to COVID-19 in patients with gastrointestinal cancer in the UK. Annals of Oncology, 34, S25. doi:10.1016/j.annonc.2023.04.090DOI: 10.1016/j.annonc.2023.04.090
Systematic review and meta-analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID-19 in immunocompromised patients (Journal article)
Suribhatla, R., Starkey, T., Ionescu, M. C. C., Pagliuca, A., Richter, A., & Lee, L. Y. W. (2023). Systematic review and meta-analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID-19 in immunocompromised patients. BRITISH JOURNAL OF HAEMATOLOGY, 201(5), 813-823. doi:10.1111/bjh.18782DOI: 10.1111/bjh.18782
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer A National COVID Cancer Cross-sectional Evaluation (Journal article)
Lee, L. Y. W., Tilby, M., Starkey, T., Ionescu, M. C., Burnett, A., Hattersley, R., . . . Johnson, P. (2023). Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer A National COVID Cancer Cross-sectional Evaluation. JAMA ONCOLOGY, 9(2), 188-196. doi:10.1001/jamaoncol.2022.5974DOI: 10.1001/jamaoncol.2022.5974
2022
Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review (Journal article)
Al Hajji, Y., Taylor, H., Starkey, T., Lee, L. Y. W., & Tilby, M. (2022). Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review. BRITISH JOURNAL OF CANCER, 127(10), 1827-1836. doi:10.1038/s41416-022-01951-yDOI: 10.1038/s41416-022-01951-y
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study (Journal article)
Lee, L. Y. W., Ionescu, M. C., Starkey, T., Little, M., Tilby, M., Tripathy, A. R., . . . Johnson, P. (2022). COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study. EUROPEAN JOURNAL OF CANCER, 175, 1-10. doi:10.1016/j.ejca.2022.06.038DOI: 10.1016/j.ejca.2022.06.038
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population- based test-negative case-control study (Journal article)
Lee, L. Y. W., Starkey, T., Ionescu, M. C., Little, M., Tilby, M., Tripathy, A. R., . . . Johnson, P. (2022). Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population- based test-negative case-control study. LANCET ONCOLOGY, 23(6), 748-757. doi:10.1016/S1470-2045(22)00202-9DOI: 10.1016/S1470-2045(22)00202-9
2021
A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2 (Journal article)
Mistry, D. A., Wang, J. Y., Moeser, M. -E., Starkey, T., & Lee, L. Y. W. (2021). A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2. BMC INFECTIOUS DISEASES, 21(1). doi:10.1186/s12879-021-06528-3DOI: 10.1186/s12879-021-06528-3
COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing (Journal article)
Peto, T. (2021). COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing. ECLINICALMEDICINE, 36. doi:10.1016/j.eclinm.2021.100924DOI: 10.1016/j.eclinm.2021.100924
Coronavirus Disease 2019: the Pivotal Role of UK Clinical Oncology and the UK Coronavirus Cancer Monitoring Project (Journal article)
Best, J., Starkey, T., Chatterjee, A., Fackrell, D., Pettit, L., Srihari, N., . . . Lee, L. Y. W. (2021). Coronavirus Disease 2019: the Pivotal Role of UK Clinical Oncology and the UK Coronavirus Cancer Monitoring Project. CLINICAL ONCOLOGY, 33(1), E50-E53. doi:10.1016/j.clon.2020.05.021DOI: 10.1016/j.clon.2020.05.021
2020
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals (Journal article)
Demetriou, P., Abu-Shah, E., Valvo, S., McCuaig, S., Mayya, V., Kvalvaag, A., . . . Dustin, M. L. (2020). A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals. NATURE IMMUNOLOGY, 21(10), 1232-+. doi:10.1038/s41590-020-0770-xDOI: 10.1038/s41590-020-0770-x
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study (Journal article)
Lee, L. Y. W., Cozier, J. -B., Starkey, T., Briggs, S. E. W., Arnold, R., Bisht, V., . . . Kerr, R. (2020). COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. LANCET ONCOLOGY, 21(10), 1309-1316. doi:10.1016/S1470-2045(20)30442-3DOI: 10.1016/S1470-2045(20)30442-3
Utility of COVID-19 Screening in Cancer Patients (Journal article)
Lee, L. Y. W., Hill, T., Topping, O., Tilby, M., Baker, M., Greig, J., . . . Middleton, G. (2020). Utility of COVID-19 Screening in Cancer Patients. CANCER CELL, 38(3), 306-307. doi:10.1016/j.ccell.2020.07.009DOI: 10.1016/j.ccell.2020.07.009
Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome? (Journal article)
Pickles, O. J., Lee, L. Y. W., Starkey, T., Freeman-Mills, L., Olsson-Brown, A., Cheng, V., . . . Middleton, G. (2020). Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?. BRITISH JOURNAL OF CANCER, 123(5), 691-693. doi:10.1038/s41416-020-0930-7DOI: 10.1038/s41416-020-0930-7
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study (Journal article)
Lee, L. Y. W., Cazier, J. B., Angelis, V., Arnold, R., Bisht, V., Campton, N. A., . . . Middleton, G. (2020). COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. LANCET, 395(10241), 1919-1926. doi:10.1016/S0140-6736(20)31173-9DOI: 10.1016/S0140-6736(20)31173-9
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19 (Journal article)
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19 (2020). LANCET ONCOLOGY, 21(5), 622-624. doi:10.1016/S1470-2045(20)30230-8DOI: 10.1016/S1470-2045(20)30230-8
Transcriptomics Identify a Unique Intermittent Hypoxia-mediated Profile in Obstructive Sleep Apnea (Journal article)
Turnbull, C. D., Lee, L. Y. W., Starkey, T., Sen, D., Stradling, J., & Petousi, N. (2020). Transcriptomics Identify a Unique Intermittent Hypoxia-mediated Profile in Obstructive Sleep Apnea. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 201(2), 247-250. doi:10.1164/rccm.201904-0832LEDOI: 10.1164/rccm.201904-0832LE
2019
ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: results of a prospective single centre clinical utility study (PRECISE STUDY) (Journal article)
Lee, L., Starkey, T., Sivakumar, S., Fotheringham, S., Mozolowski, G., Shearwood, V., . . . Kerr, D. (2019). ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: results of a prospective single centre clinical utility study (PRECISE STUDY). Annals of Oncology, 30, iv11. doi:10.1093/annonc/mdz155.038DOI: 10.1093/annonc/mdz155.038
Serum- and Glucocorticoid-induced Kinase Sgk1 Directly Promotes the Differentiation of Colorectal Cancer Cells and Restrains Metastasis (Journal article)
Lee, L. Y. W., Woolley, C., Starkey, T., Biswas, S., Mirshahi, T., Bardella, C., . . . Tomlinson, I. (2019). Serum- and Glucocorticoid-induced Kinase Sgk1 Directly Promotes the Differentiation of Colorectal Cancer Cells and Restrains Metastasis. CLINICAL CANCER RESEARCH, 25(2), 629-640. doi:10.1158/1078-0432.CCR-18-1033DOI: 10.1158/1078-0432.CCR-18-1033
2018
STAT3 cyclic oligonucleotide decoy-a new therapeutic avenue for NSCLC? (Journal article)
Lee, L. Y. W., Mohammad, S., Starkey, T., & Lee, S. -M. (2018). STAT3 cyclic oligonucleotide decoy-a new therapeutic avenue for NSCLC?. TRANSLATIONAL LUNG CANCER RESEARCH, 7, S381-S384. doi:10.21037/tlcr.2018.09.14DOI: 10.21037/tlcr.2018.09.14
